Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Dr. Kingsley R. Chin Invites Jamaicans to Invest in Cutting-Edge Spine Surgery Technologies for the Future


News provided by

KIC Ventures

Jun 06, 2024, 05:00 ET

Share this article

Share toX

Share this article

Share toX

Invest and become an owner with Dr. Kingsley R. Chin and KIC Ventures in Revolutionizing Spine Technologies
Invest and become an owner with Dr. Kingsley R. Chin and KIC Ventures in Revolutionizing Spine Technologies

Dr. Kingsley R. Chin, a Jamaican-born spinal surgeon and entrepreneur, aims to transform Jamaica into a leader in spine technologies through KIC Ventures. He invites Jamaicans to invest in this venture, offering a unique opportunity to build wealth and support medical innovation. KIC Ventures is raising $15 million USD, with shares at $60 each and a minimum investment of $25,000 USD. With a current valuation of $300 million, the company is poised for significant growth, including the release of AxioMed's lumbar disc replacement in 2025. Dr. Chin's groundbreaking contributions to spine surgery and his commitment to philanthropy in Jamaica showcase his visionary leadership. Join Dr. Chin and KIC Ventures in building a global Jamaican technology brand and leading in spine surgery innovation.

BURLINGTON, Mass., June 6, 2024 /PRNewswire-PRWeb/ -- Dr. Kingsley R. Chin, a Jamaican-born orthopedic spinal surgeon and entrepreneur, is on a mission to transform Jamaica into the "Wakanda for Spine Technology" through his company, KIC Ventures. With a proven track record of groundbreaking advancements in spine surgery, Dr. Chin is inviting Jamaicans worldwide to join him in this revolutionary journey by investing in KIC Ventures.

What's in It for You?
By investing in KIC Ventures, Jamaicans have a unique opportunity to diversify their portfolios, build substantial wealth, and contribute to a legacy of medical innovation. This investment not only supports a Jamaican-led company but also helps build a future where Jamaica is recognized globally for its technological advancements in spine surgery.

"This is a unique chance for Jamaican investors to support cutting-edge spine surgery and impact their financial futures. Together, we can position Jamaica as a leader in spine technologies," said Dr. Kingsley R. Chin, Founder and CEO of KIC Ventures.

Post this

Why You Should Invest
KIC Ventures is revolutionizing spine surgery with innovative technologies. Accredited investors can now participate in this transformative journey by investing in the company's Series A offering. With a goal to raise $15 million USD, shares are priced at $60 USD each, with a minimum investment of $25,000 USD. This offering is rapidly gaining traction, with several million already secured since its opening from a mix of physicians and non-physicians, and is expected to close soon this year.

Proven Value Growth: From $100,000 Investment to $300 Million Valuation
In 2006, Dr. Chin laid the foundation for KIC Ventures with a personal investment of $100,000, targeting unique spine technologies. His strategic vision and commitment have led him to invest an estimated $40+ million of his own capital and attract an additional $25 million from external investors over time. Today, KIC Ventures boasts an impressive valuation of $300 million, with Dr. Chin owning more than 50%—demonstrating a remarkable 3,000x return on his initial investment.

Dr. Chin emphasizes that now is the optimal time for investors to join, as many initial risks have been mitigated, and KIC Ventures is positioned for global expansion and pursuing US IPOs for its portfolio companies. A prime example of this success is NANISX, which has shown consistent profitability since 2021, maintaining a positive EBITDA. The highly anticipated 2025 release of AxioMed's lumbar disc replacement to US surgeons is expected to further accelerate growth, with an ambitious target to elevate the company's valuation to $5 billion.

Why You Should Trust Dr. Kingsley R. Chin
Dr. Kingsley R. Chin's remarkable journey from a small town in Jamaica to becoming a trailblazing CEO in the spine surgery technology revolution is a testament to his resilience, determination, and visionary leadership. Raised in Buff Bay by a single mother, Dr. Chin's early life instilled in him the values of hard work and perseverance. His academic excellence earned him a scholarship to Columbia University, where he excelled both academically and athletically, becoming the Ivy League Player of the Year in soccer and president of his senior class.

Dr. Chin's career trajectory took him from prestigious institutions like AT&T Bell Labs and Accenture to Harvard Medical School and Harvard Business School. As the Chief Spine Surgeon at the University of Pennsylvania, he pioneered innovative approaches that revolutionized spine surgery, earning global recognition for his transformative impact.

Why You Should Respect His Accomplishments
Dr. Chin's contributions to spine surgery are unparalleled. He introduced the game-changing MANTIS technology, which reshaped how spine surgeries are performed and was acquired by Stryker Spine in 2005. As the Founder and CEO of KIC Ventures, Dr. Chin continues to lead advancements in outpatient Less Exposure Spine Surgery (LESS™) technologies, consistently enhancing patient outcomes.

Despite facing challenges, including defending against anti-kickback charges by the Department of Justice, Dr. Chin's commitment to excellence has remained steadfast. His resilience and innovative spirit have set the foundation to propel KIC Ventures to unprecedented future growth, with NANISX portfolio revenues soaring over 40% year over year since 2021 and Axiomed lumbar viscoelastic disc replacement nearing FDA approval in 2025.

Why You Should Believe in Him and KIC Ventures
KIC Ventures is dedicated to revolutionizing spine surgery with cutting-edge technologies. Dr. Chin's acquisition of Axiomed, with its potential to disrupt traditional spine surgeries and improve patient outcomes, further solidifies his position as a visionary leader in the field. His deep understanding of both medical and business realms makes him a leader investors cannot afford to overlook.

Dr. Kingsley R. Chin's Dedication to Philanthropy
Dr. Chin's commitment to philanthropy is exemplified by his strategic initiatives and notable accolades. He has long supported local sports and education in Jamaica. Dr. Chin stepped in to support the struggling St. George's Football Club in his hometown of Buff Bay, Portland, Jamaica, renaming it Portlanders FC and elevating its performance. He also supports his alma mater, Titchfield High School, and the Reggae Girlz Football Team. In education, Dr. Chin volunteers as an adjunct professor at the University of Technology, Kingston, Jamaica, and has funded the construction of a science lab in Kingston.

In 2008, Dr. Chin founded the LESS Society, a 501(c)(3) organization promoting LESS Exposure Spine Surgery techniques. He also established the Healthtech Ventures Network Conference (HTVNC) to bring together healthcare professionals, entrepreneurs, and investors to discuss the future of the healthtech industry.

Dr. Chin's distinguished service has been recognized through numerous honors, including being named the Young Caribbean Professional Network (YCPN) International Entrepreneur of the Year in Philadelphia at their national event in 2018 and receiving the 2019 Caribbean American Heritage (CARAH) Award for medicine.

Join Us in Building a Global Jamaican Technology Brand
KIC Ventures invites Jamaicans, both at home and in the diaspora, to join this groundbreaking journey. Dr. Chin envisions a future where Jamaica leads in spine technology innovation, creating opportunities for young graduates and positioning the country as a global technology hub.

To learn more about Dr. Kingsley R. Chin and KIC Ventures, visit http://www.kicventures.com. Discover how you can invest in this pioneering company and be part of a transformative journey that is shaping the future of spine surgery and healthcare.

About KIC Ventures
KIC Ventures is a leading healthtech company dedicated to revolutionizing spine surgery with innovative technologies. Founded by Harvard graduate orthopedic spine surgeon and entrepreneur, Dr. Kingsley R Chin, the company is committed to improving patient outcomes and supporting healthcare providers through advanced spine technologies worldwide.

This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities.

Media Contact

Aditya Humad, KIC Ventures, 978-232-3990, Investor@KICVentures.com, www.KICVentures.com 

SOURCE KIC Ventures

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.